> top > docs > PMC:7283670 > spans > 61047-61370 > annotations

PMC:7283670 / 61047-61370 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T220 291-296 Body_part denotes mouth http://purl.org/sig/ont/fma/fma49184

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T142 291-296 Body_part denotes mouth http://purl.obolibrary.org/obo/UBERON_0000165

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T361 99-107 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T362 177-185 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T571 291-296 http://www.ebi.ac.uk/efo/EFO_0000825 denotes mouth

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T34447 14-33 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T27940 14-23 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T20411 24-33 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T71837 37-55 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T131 116-135 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T12779 116-125 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T42223 126-135 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T53502 143-161 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T77554 162-169 Chemical denotes sulfate http://purl.obolibrary.org/obo/CHEBI_16189
T82580 244-263 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T91739 244-253 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T7801 254-263 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T633 0-323 Sentence denotes Comparison of lopinavir/ritonavir or hydroxychloroquine in patients with mild coronavirus disease (COVID‐19) Drug: lopinavir/ritonavir, Drug: hydroxychloroquine sulfate Korea/COVID‐19 150, all, 16 years to 99 years Treatment Experimental: lopinavir/ritonavir 200 mg/100 mg 2 tablets by mouth, every 12 hr for 7–10 days

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1887 59-67 Species denotes patients Tax:9606
2055 14-33 Chemical denotes lopinavir/ritonavir MESH:C558899
2056 116-135 Chemical denotes lopinavir/ritonavir MESH:C558899
2057 244-263 Chemical denotes lopinavir/ritonavir MESH:C558899
2121 78-97 Disease denotes coronavirus disease MESH:D018352
2122 99-107 Disease denotes COVID‐19 MESH:C000657245
2123 177-185 Disease denotes COVID‐19 MESH:C000657245